Wall Street Zen Upgrades Callan JMB (NASDAQ:CJMB) to Hold

Callan JMB (NASDAQ:CJMB) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a research report issued on Saturday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Callan JMB in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Callan JMB currently has an average rating of “Sell”.

Callan JMB Stock Down 29.3%

Shares of CJMB stock opened at $1.28 on Friday. The firm has a 50 day moving average price of $1.89 and a two-hundred day moving average price of $2.75. The company has a market capitalization of $5.91 million and a PE ratio of -1.03. Callan JMB has a 12-month low of $1.08 and a 12-month high of $5.88.

Insider Activity at Callan JMB

In other Callan JMB news, insider David J. Croyle purchased 14,805 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were acquired at an average cost of $1.76 per share, with a total value of $26,056.80. Following the completion of the transaction, the insider owned 789,805 shares in the company, valued at $1,390,056.80. The trade was a 1.91% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 73.87% of the company’s stock.

Institutional Trading of Callan JMB

An institutional investor recently raised its position in Callan JMB stock. Creative Planning lifted its stake in shares of Callan JMB Inc. (NASDAQ:CJMB) by 41.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 170,008 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Creative Planning owned 3.79% of Callan JMB worth $830,000 as of its most recent SEC filing.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.